Andrew lo's Net Worth
-$74.7 Million
Who is Andrew lo?
Andrew lo does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Arbutus Biopharma Corp, Myovant Sciences Ltd., Roivant Sciences Ltd., BridgeBio Pharma, Inc., AbCellera Biologics Inc., Urovant Sciences Ltd., and Axovant Gene Therapies Ltd..
SEC CIK
Andrew lo's CIK is 0001679076
Past Insider Trading and Trends
2019 was Andrew lo's most active year for acquiring shares with 28 total transactions. Andrew lo's most active month to acquire stocks was the month of May. 2018 saw Andrew lo paying a total of $161,399,997.55 for 28,738,300 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arbutus Biopharma Corp (ABUS) Snapshot price: $2.491
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.32% | 2.42M |
$8.25 | $19,999,996.50 | 40.77M |
Jun 4
| |||
Form 4
| +2.98% | 1.11M |
$20.27 | $22,500,004.05 | 38.34M |
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Roivant Sciences Ltd. (ROIV) Snapshot price: $10.395
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 52.14K |
—
|
—
| 52.14K |
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BridgeBio Pharma, Inc. (BBIO) Snapshot price: $33.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +18.47% | 7.5K |
$13.18 | $98,850.00 | 48.1K |
Dec 29 - Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AbCellera Biologics Inc. (ABCL) Snapshot price: $4.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
∞
| 86.94K |
$14.02 | $1,218,870.76 | 86.94K |
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||